Immediate Impact
1 by Nobel laureates 1 from Science/Nature 66 standout
Citing Papers
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
2023 Standout
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
2022 Standout
Works of E. Montegriffo being referenced
Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non–Small-Cell Lung Cancer
2012
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| E. Montegriffo | 33 | 94 | 23 | 148 | 140 | 6 | 267 | |
| W. Messersmith | 5 | 95 | 32 | 203 | 87 | 9 | 298 | |
| R Canaletti | 7 | 105 | 9 | 172 | 63 | 7 | 307 | |
| Victoria Kaestner | 26 | 38 | 13 | 154 | 58 | 6 | 303 | |
| Jacques Cretin | 18 | 44 | 5 | 167 | 85 | 9 | 324 | |
| Nikolas Tsavaris | 7 | 33 | 7 | 191 | 125 | 11 | 323 | |
| Tomohiro Funakoshi | 6 | 94 | 6 | 109 | 109 | 11 | 320 | |
| Charles L. Wiggins | 21 | 120 | 7 | 194 | 64 | 12 | 318 | |
| Seon-Hee Yim | 19 | 73 | 7 | 129 | 57 | 11 | 297 | |
| Matthew Boron | 85 | 28 | 41 | 154 | 80 | 6 | 295 | |
| Tyler B. Kratzer | 16 | 81 | 8 | 131 | 102 | 8 | 319 |
All Works
Loading papers...